Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.18 - $0.48 $24,988 - $66,635
138,824 Added 59.85%
370,759 $111,000
Q1 2023

May 15, 2023

BUY
$0.34 - $1.19 $28,036 - $98,128
82,461 Added 55.17%
231,935 $100,000
Q4 2022

Feb 14, 2023

BUY
$1.03 - $2.0 $111,635 - $216,768
108,384 Added 263.77%
149,474 $176,000
Q3 2022

Nov 14, 2022

SELL
$0.42 - $3.92 $1,011 - $9,443
-2,409 Reduced 5.54%
41,090 $95,000

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0

About GreenLight Biosciences Holdings, PBC


  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.